Y-Intercept (HK)’s Adaptive Biotechnologies ADPT Stock Holding History

Y-Intercept (HK)’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.63M	Sell	125,483 -9,654	-7%	-$237K	0.08%	361
2026 Q2	$2.9M	Buy	+135,137	New	+$2.07M	0.06%	495
2026 Q1	–	Sell	-23,777	Closed	-$386K	–	1507
2025 Q4	$386K	Buy	+23,777	New	+$388K	0.01%	1307
2024 Q3	–	Sell	-67,252	Closed	-$243K	–	1251
2024 Q2	$243K	Buy	+67,252	New	+$213K	0.01%	1103
2023 Q3	–	Sell	-18,310	Closed	-$123K	–	1010
2023 Q2	$123K	Sell	18,310 -8,816	-33%	-$65.6K	0.01%	1035
2023 Q1	$240K	Buy	+27,126	New	+$239K	0.03%	873
2022 Q2	–	Sell	-14,876	Closed	-$206K	–	832
2022 Q1	$206K	Buy	+14,876	New	+$234K	0.05%	605
2021 Q2	–	Sell	-8,040	Closed	-$302K	–	598
2021 Q1	$302K	Buy	8,040 +3,647	+83%	+$197K	0.08%	400
2020 Q4	$261K	Buy	+4,393	New	+$227K	0.11%	360

Other funds holding ADPT

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Warsaw $291M AUM 52.67% 1-Year Est. Return

WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s ADPT Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Adaptive Biotechnologies (ADPT) stake by 7.1% in Q3 2026, selling an estimated $237K and leaving 125,483 shares worth $3.63M. The position accounts for 0.08% of the portfolio, ranked #361.

Y-Intercept (HK) first reported a position in ADPT in Q4 2020 and has held it in 9 quarters since. 34 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

Y-Intercept (HK) held 125,483 shares of Adaptive Biotechnologies worth $3.63M as of Q3 2026.
Y-Intercept (HK) sold 9,654 Adaptive Biotechnologies shares in Q3 2026, an estimated $237K.
Adaptive Biotechnologies made up 0.08% of Y-Intercept (HK)'s portfolio in Q3 2026, its #361 holding.
Y-Intercept (HK) first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 9 quarters since.
34 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.